Literature DB >> 20564276

Proteins as possible targets for cytotoxic trans-platinum(II) complexes with aliphatic amine ligands: Further exceptions to the DNA paradigm.

Leticia Cubo1, Michael Groessl, Paul J Dyson, Adoración G Quiroga, Carmen Navarro-Ranninger, Angela Casini.   

Abstract

The reactivity of three cytotoxic trans-Pt(II) complexes bearing aliphatic amine ligands, with transferrin and single-stranded oligonucleotides as DNA models, was investigated by ESI-MS and the results obtained are discussed in comparison with cisplatin. Tandem MS studies provided additional information on the preferential Pt binding sites. To determine whether trans-Pt(II) complexes can migrate from a peptide to an oligonucleotide, transfer experiments were also performed using ESI-MS, and competitive binding of the trans-Pt(II) complexes toward a model peptide and different oligonucleotides was also investigated. Significant differences in the reactivity of the trans complexes with respect to cisplatin were observed. In general, adduct formation with the selected peptide is favored for the trans compounds, whereas cisplatin shows a preference for oligonucleotides, especially if adjacent G-G residues are present. The results are discussed in relation to the possible mechanism of action of the trans-Pt(II) complexes.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20564276      PMCID: PMC3920175          DOI: 10.1002/cmdc.201000104

Source DB:  PubMed          Journal:  ChemMedChem        ISSN: 1860-7179            Impact factor:   3.466


  44 in total

Review 1.  Current status of the development of trans-platinum antitumor drugs.

Authors:  J M Pérez; M A Fuertes; C Alonso; C Navarro-Ranninger
Journal:  Crit Rev Oncol Hematol       Date:  2000-08       Impact factor: 6.312

2.  Rates of platination of -AG- and -GA- containing double-stranded oligonucleotides: effect of chloride concentration.

Authors:  M S Davies; S J Berners-Price; T W Hambley
Journal:  J Inorg Biochem       Date:  2000-04       Impact factor: 4.155

Review 3.  The role of cellular accumulation in determining sensitivity to platinum-based chemotherapy.

Authors:  Matthew D Hall; Mitsunori Okabe; Ding-Wu Shen; Xing-Jie Liang; Michael M Gottesman
Journal:  Annu Rev Pharmacol Toxicol       Date:  2008       Impact factor: 13.820

4.  Ruthenium versus platinum: interactions of anticancer metallodrugs with duplex oligonucleotides characterised by electrospray ionisation mass spectrometry.

Authors:  Michael Groessl; Yury O Tsybin; Christian G Hartinger; Bernhard K Keppler; Paul J Dyson
Journal:  J Biol Inorg Chem       Date:  2010-03-07       Impact factor: 3.358

5.  Interpretation of oligonucleotide mass spectra for determination of sequence using electrospray ionization and tandem mass spectrometry.

Authors:  J Ni; C Pomerantz; J Rozenski; Y Zhang; J A McCloskey
Journal:  Anal Chem       Date:  1996-07-01       Impact factor: 6.986

6.  Interactions of cisplatin and transplatin with proteins. Comparison of binding kinetics, binding sites and reactivity of the Pt-protein adducts of cisplatin and transplatin towards biological nucleophiles.

Authors:  Tal Peleg-Shulman; Yousef Najajreh; Dan Gibson
Journal:  J Inorg Biochem       Date:  2002-07-25       Impact factor: 4.155

7.  The synergistic binding of anions and Fe3+ by transferrin. Implications for the interlocking sites hypothesis.

Authors:  M R Schlabach; G W Bates
Journal:  J Biol Chem       Date:  1975-03-25       Impact factor: 5.157

8.  High resolution mass spectrometry for studying the interactions of cisplatin with oligonucleotides.

Authors:  Alexander E Egger; Christian G Hartinger; Hisham Ben Hamidane; Yury O Tsybin; Bernhard K Keppler; Paul J Dyson
Journal:  Inorg Chem       Date:  2008-10-24       Impact factor: 5.165

9.  Platinum metallodrug-protein binding studies by capillary electrophoresis-inductively coupled plasma-mass spectrometry: characterization of interactions between Pt(II) complexes and human serum albumin.

Authors:  Andrei R Timerbaev; Svetlana S Aleksenko; Kasia Polec-Pawlak; Rafal Ruzik; Olga Semenova; Christian G Hartinger; Slawomir Oszwaldowski; Markus Galanski; Maciej Jarosz; Bernhard K Keppler
Journal:  Electrophoresis       Date:  2004-07       Impact factor: 3.595

10.  The influence of Cisplatin on the gas-phase dissociation of oligonucleotides studied by electrospray ionization tandem mass spectrometry.

Authors:  Adrien Nyakas; Michael Eymann; Stefan Schürch
Journal:  J Am Soc Mass Spectrom       Date:  2008-12-31       Impact factor: 3.262

View more
  4 in total

1.  Platinum-based drugs and proteins: reactivity and relevance to DNA adduct formation.

Authors:  Odra Pinato; Caterina Musetti; Nicholas P Farrell; Claudia Sissi
Journal:  J Inorg Biochem       Date:  2013-01-23       Impact factor: 4.155

2.  Mass spectrometry-guided optimization and characterization of a biologically active transferrin-lysozyme model drug conjugate.

Authors:  Son N Nguyen; Cedric E Bobst; Igor A Kaltashov
Journal:  Mol Pharm       Date:  2013-04-10       Impact factor: 4.939

3.  Organometallic Palladium Complexes with a Water-Soluble Iminophosphorane Ligand as Potential Anticancer Agents.

Authors:  Monica Carreira; Rubén Calvo-Sanjuán; Mercedes Sanaú; Isabel Marzo; María Contel
Journal:  Organometallics       Date:  2012-07-25       Impact factor: 3.876

4.  Simultaneous mass spectrometry analysis of cisplatin with oligonucleotide-peptide mixtures: implications for the mechanism of action.

Authors:  Farangis Mansouri; Luc Patiny; Daniel Ortiz; Laure Menin; Curtis A Davey; Fakhrossadat Mohammadi; Paul J Dyson
Journal:  J Biol Inorg Chem       Date:  2022-01-22       Impact factor: 3.358

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.